Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WHO promises new global focus on hep C diagnostics

This article was originally published in Clinica

Executive Summary

The World Health Organization (WHO) is to develop a "comprehensive approach to the prevention and control" of five types of viral hepatitis, promising an important focus on diagnostics. The plans were endorsed by the WHO's member states on 21 April, through a resolution that features a number of measures to improve healthcare and public awareness of the condition. Hepatitis A, B, C, D and E are thought to jointly account for over one million deaths per year, according to the WHO. "An estimated one in 12 people are infected with hepatitis C and have to face a life with liver disease if unrecognised," it said.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094775

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel